Clinuvel Pharmaceuticals
CUV.AX
#7410
Rank
A$0.57 B
Marketcap
$11.40
Share price
1.33%
Change (1 day)
-27.49%
Change (1 year)

EPS for Clinuvel Pharmaceuticals (CUV.AX)

EPS in 2023: $0.64

According to Clinuvel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $0.64. In 2023 the company made an earnings per share (EPS) of $0.64 an increase over its 2022 EPS that were of $0.46.

EPS history for Clinuvel Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023$0.6440.79%
2022$0.46-22.53%
2021$0.5961.74%
2020$0.37-12.03%
2019$0.4228.75%
2018$0.3279.08%
2017$0.18-318.99%
2016-$0.08229-71.6%
2015-$0.2936.75%
2014-$0.21-23.66%
2013-$0.28-45.84%
2012-$0.51-18.99%
2011-$0.6325.76%
2010-$0.50-22.24%
2009-$0.65-10.59%
2008-$0.7246.78%
2007-$0.49-34.2%
2006-$0.75-25.89%
2005-$1.0140.91%
2004-$0.7255.12%
2003-$0.4652.02%
2002-$0.3071.69%
2001-$0.18355.46%
2000-$0.03891